Background The association of pulmonary embolism (PE) with deep vein thrombosis (DVT)
in patients with coronavirus disease 2019 (COVID-19) remains unclear, and the diagnostic …

Without modern medical management and vaccines, the severity of the Coronavirus
Disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome (SARS) …

Background REGEN-COV is a combination of 2 monoclonal antibodies (casirivimab and
imdevimab) that bind to two different sites on the receptor binding domain of the SARS-CoV …

Background Aspirin has been proposed as a treatment for COVID-19 on the basis of its anti-
thrombotic properties. We aimed to evaluate the efficacy and safety of aspirin in patients …

Acute respiratory distress syndrome (ARDS) is a complex syndrome of acute lung injury
leading to noncardiogenic pulmonary edema from many causes that is heterogenous in its …

In the 3rd year of the SARS-CoV-2 pandemic, much has been learned about the long-term
effects of COVID-19 pneumonia on the lungs. Approximately one-third of patients with …

The severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) pandemic has had
devastating effects on global health and worldwide economy. Despite an initial reluctance to …

Since the vast majority of species solely rely on innate immunity for host defense, it stands to
reason that a critical evolutionary trait like immunological memory evolved in this primitive …

Abstract Coronavirus Disease 2019 (COVID-19), caused by the novel Severe Acute
Respiratory Syndrome–associated Coronavirus 2 (SARS-CoV-2), has become a global …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has now affected over 72.5
million people worldwide, with nearly 1.6 million deaths reported globally as of December …